
Journal of Medicinal Chemistry p. 6871 - 6885 (2013)
Update date:2022-07-30
Topics:
Kokatla, Hari Prasad
Sil, Diptesh
Malladi, Subbalakshmi S.
Balakrishna, Rajalakshmi
Hermanson, Alec R.
Fox, Lauren M.
Wang, Xinkun
Dixit, Anshuman
David, Sunil A.
Toll-like receptor (TLR)-8 agonists activate adaptive immune responses by inducing robust production of T helper 1-polarizing cytokines, suggesting that TLR8-active compounds may be promising candidate adjuvants. We synthesized and evaluated hitherto unexplored furo[2,3-c]quinolines and regioisomeric furo[3,2-c]quinolines derived via a tandem, one-pot Sonogashira coupling and intramolecular 5-endo-dig cyclization strategy in a panel of primary screens. We observed a pure TLR8-agonistic activity profile in select furo[2,3-c] quinolines, with maximal potency conferred by a C2-butyl group (EC50 = 1.6 μM); shorter, longer, or substituted homologues as well as compounds bearing C1 substitutions were inactive, which was rationalized by docking studies using the recently described crystal structure of human TLR8. The best-in-class compound displayed prominent proinflammatory cytokine induction (including interleukin-12 and interleukin-18), but was bereft of interferon-α inducing properties, confirming its high selectivity for human TLR8.
View MoreContact:18669908765
Address:Zibo City, Shandong Province, P.R.China
Zhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Shanghai Korey Pharm Co.,Ltd.(expird)
Contact:021-61840961 021-61840962
Address:No.157,Zhuguang Rd, Qingpu, Shanghai, China
Beijing Cooperate Pharmaceutical Co.,Ltd
website:http://www.cooperate-pharm.com/
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Contact:86-510-82853889
Address:Rm.3732, No.18-2,Yonghe Rd.,Wuxi,Jiangsu,214023,China
Doi:10.1016/0040-4039(92)89045-E
(1992)Doi:10.1016/j.bmc.2013.06.014
(2013)Doi:10.1039/c6cc07119h
(2016)Doi:10.1002/aoc.3030
(2013)Doi:10.1002/cmdc.201700302
(2017)Doi:10.1055/s-1993-25976
(1993)